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Dialysis-associated ischemic heart disease: Insights from coronary
angiography. We reviewed the records of 44 dialysis patients who had
undergone one or more coronary angiograms to determine the frequen-
cy with which symptomatic ischemic heart disease (IHD) and signifi-
cant coronary artery narrowing coincided and to determine those
factors which were associated with the coronary atherosclerotic proc-
ess. Thirty-four patients were catheterized for angina pectoris or
myocardial infarction. Of this group, 53% were found to have signifi-
cant narrowing of coronary arteries. This group was older than the
group with trivial or no coronary artery occlusion and their duration of
dialysis was shorter. All the patients with significant coronary occlusion
were white and the majority were adult males. Discriminant function
analysis revealed that the presence of significant coronary artery
occlusion could be predicted with high sensitivity and specificity by the
following variables: older age, white race, male sex, the presence of
symptomatic IHD prior to the onset of dialysis, increased total serum
cholesterol, abnormal left ventricular wall motion, and reduced alkaline
phosphatase. We also found that the occurrence of symptomatic IHD
far exceeded the presence of significant atherosclerotic coronary artery
narrowing. We suggest that this may result from several dialysis-
associated alterations in oxygen delivery and myocardial oxygen
consumption.
Cardiopathie ischemique associée a Ia dialyse: Données de l'angiogra.
phie coronarienne. Nous avons revu les dossiers de 44 malades hCmo-
dialyses qui avaient eu une ou plusieurs coronarographies afin de
determiner Ia frequence avec laquelle une cardiopathie ischémique
symptomatique (IHD) et une stCnose significative d'une artère coro-
naire ont coIncide, et afin de determiner les facteurs qui étaient associés
avec Ic processus d'artériosclérose coronaire. Trente-quatre malades
ont été cathéterises en raison d'une angine de poitrine ou d'un infarctus
du myocarde. Dans ce groupe, 53% avaient une sténose significative
des artères coronaires. Ce groupe était plus hgé que le groupe avec une
stCnose de l'artère coronaire minime ou nulle, et Ia duree en dialyse
était plus courte. Tous les malades avec une obstruction coronaire
significative étaient blancs, et Ia majorité était des males adultes. Une
analyse des fonctions discriminantes a révélC que Ia presence d'une
occlusion significative d'une artère coronaire pouvait être predite avec
une sensibilite et une specificite elevees par les variables suivantes: age
plus grand, race blanche, sexe masculin, presence d'IHD symptoma-
tique avant Ia mise en hemodialyse, augmentation du cholesterol
sCrique total, cinetique de Ia paroi ventriculaire gauche anormale, et
reduction des phosphatases alcalines. Nous avons egalement trouvé
que Ia survenue d'une IHD symptomatique dCpassait de loin Ia pres-
ence d'une stCnose arteriosclereuse coronaire significative. Nous sug-
gèrons que cela pourrait resulter de plusiers alterations, associees a La
dialyse, dans l'apport en oxygene et Ia consommation en oxygène du
myocarde.
sis. Indeed, during this time, overall cardiovascular mortality in
this population has remained relatively constant at about 30%,
of which 10% are myocardial infarction deaths, despite a well-
documented decline in such mortality in the general population
[1—4]. This observation, together with an increased prevalence
of established coronary risk factors, has led to the idea that
coronary atherosclerosis may be accelerated in uremic patients
[5—6]. To date and to our knowledge, there have been few
studies which have examined the pathogenesis of atherosclero-
sis in experimental uremia and none have confirmed this
hypothesis [7—81. In this regard, most studies of dialysis popula-
tions have been epidemologic, emphasizing the association of
IHD with hypertension, especially that occurring prior to the
onset of dialysis [9—12]. Associations with smoking and serum
triglyceride concentrations have also been made [12], although
the latter findings are not agreed upon [13, 14]. Recently, we
described a coronary risk profile for our hemodialysis patients
which, in addition to elevated diastolic BP, included advanced
age and race (white) as important determinants for symptomatic
IHD [9]. However, interpretation of these several studies has
been complicated by the use of different end points for cardio-
vascular disease, including the appearance of myocardial in-
farction, angina, stroke, or their associated mortality, and by
differences in the racial composition of the study populations.
Moreover, few studies have examined systematically the asso-
ciation of these risk factors with documented coronary athero-
sclerosis. The latter is an important consideration since it is well
known that symptomatic IHD (angina pectoris and occasionally
myocardial infarction) may occur in the absence of significant
coronary artery narrowing [15].
In the present study, we reviewed the records of 44 uremic
patients who had undergone one or more coronary angiographic
examinations with or without attendant ventriculography to
determine the frequency with which symptomatic IHD and
significant coronary artery disease coincided and to determine
more accurately those factors which best predicted the pres-
ence of significant coronary artery narrowing by the atheroscle-
rotic process.
During the past two decades, cardiovascular disease, espe-
cially ischemic heart disease (IHD), has been one of the leading
causes of death in patients undergoing maintenance hemodialy-
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Table 1. Indications for coronary angiography
Indication Number
Group 1
Symptomatic IHD 34
Group 2
Cardiomyopathy 2
Valvular heart diseasea 3
Experimental protocol" 5
The number includes one patient with infective endocarditis.b The protocol evaluates hypertensive heart disease.
Methods
We reviewed the records of 44 patients who entered the
maintenance dialysis program at the University of Alabama in
Birmingham and at the Birmingham Veterans Administration
Medical Center between January, 1971, and June, 1982, and
who underwent coronary angiography during the same time.
Table 1 shows the indications for coronary angiography. Thirty-
four patients (group 1) were studied because they developed
symptoms of coronary artery disease (angina pectoris, 33
patients; myocardial infarction, I patient) either during dialysis
(22 patients) or between dialysis treatments (12 patients). This
group could be further subdivided into those patients who had
angiographically significant coronary artery narrowing (group
lA) and those with normal coronary arteries or with insignifi-
cant coronary artery narrowing (group 1B). The remaining ten
patients (group 2) were studied for reasons other than symp-
toms of ischemic heart disease (valvular heart disease, three
patients, including one with infective endocarditis; cardiomyop-
athy, two patients; and, experimental studies of hypertensive
heart disease, five patients). The mean interval from the onset
of dialysis until the time of cardiac catheterization was 36.9
5.1 (SE) months (range, ito 135 months). In addition, five of the
44 patients had two coronary angiograms. At the time of
coronary angiography, ten patients were being dialyzed with
twin-coil dialyzers and 34 were using hollow fiber dialyzers. All
patients were dialyzed with standard acetate-containing baths.
Of the 44 patients studied, six were not receiving anti-anginal
medication, 33 used short- or long-acting nitrates, 15 used
digoxin, and 13 were using beta-blockers.
Angina pectoris or myocardial infarction was diagnosed when
typical symptoms and signs, including electrocardiographic
(ECG) changes, occurred. The diagnosis of myocardial infarc-
tion was confirmed by serial electrocardiographic QRST
changes and enzyme changes. Selective coronary angiography
was performed in at least two oblique projections by the
Judkins technique. Significant anatomic coronary artery nar-
rowing was diagnosed when coronary angiograms revealed a
50% or greater occlusion of one or more major coronary vessels
and early branches. This degree of luminal narrowing (50%)
seen on angiography has been felt to be associated with a 75%
or more cross-sectional narrowing observed by direct anatomi-
cal study and has been most often associated with underestima-
tions of anatomical luminal narrowing [16]. In the present
study, autopsy corroboration of angiographic findings was
made in seven patients. Left ventricular wall motion was
documented by ventriculogram in all but two patients and by
echocardiogram or scintiscan in six patients.
Left ventricular hypertrophy (LVH) was diagnosed using the
Table 2. Demographic characteristics of 44 hemodialysis patients who
underwent coronary angiography and cardiac catheterizationa
Age
years
Race
Black White
Sex
Male Female
Total
(N = 44)
50.1 12
(27.3)
32
(72.7)
25
(56.8)
19
(43.2)
Group 1(N = 34)
50.7 6
(17.6)
28
(82.4)
20
(58.8)
14
(41.2)
Group2(N = 10)
48.2 6
(60)
4
(40)
5
(50)
5
(50)
Values are mean SE except for race and sex which are the
numbers of patients. The numbers in parentheses are percentages.
Estes ECG criteria [17] and was confirmed at catheterization.
Fasting plasma triglyceride and cholesterol concentrations rep-
resent the mean of all values obtained during the course of
hemodialysis and were determined by standard laboratory
techniques. Age-related normal values were similar to those
described by Fredrickson, Levy, and Lees [18]. BP represents
the average BP recorded at each clinic visit during the course of
hemodialysis. The calcium times phosphorus product (Ca x P)
and alkaline phosphatase represent the means of from 3 to 15
determinations depending on the duration of hemodialysis. The
peak parathyroid hormone (PTH) level represents the highest
PTH level obtained prior to angiography or prior to parathy-
roidectomy, whichever came first. PTH was measured using a
radioimmunoassay which detected the intact hormone. The
packed red cell blood volume (PCV) represented the average of
five to six values obtained for each year of dialysis. Patients
were considered to have positive smoking histories if ten or
more cigarettes were smoked per day. Pipe and cigar smoking,
tobacco chewing, and snuff usage occurred infrequently and
were not included in the consideration of tobacco use.
Comparisons of group data were made by x2 and analysis of
covariance. Using discriminant function analysis, an investiga-
tion was also made into the possible joint contribution of
variables recorded for these patients to the likelihood of having
angiographic evidence of significant narrowing of one or more
coronary vessels.
Results
Characteristics of 44 patients undergoing coronary
angiography during hemodialysis
Table 2 reveals that the mean age of the study population was
50.1 1.9 years with a range of 22 to 77 years. Of these
patients, 73% were white and 27% were black while men
outnumbered women 59% to 40%. Thirty-four patients were
studied because of symptomatic ischemic heart disease (group
1) and ten patients (group 2) were studied for other reasons.
Table 2 shows that while there were more men than women in
group 1, compared to an equal distribution of men and women
in group 2, this difference in sex distribution was not statistical-
ly significant. White patients predominated in group 1. When
compared with the almost equal division between the races in
group 2, the racial differences were significant [x2 (I) = 6.98, P
= 0.008]. Compared to patients in group 2, white men were
found more often in group 1 than in group 2 [x2(3) = 13.08, P
0.004]. The mean ages of the two groups were not significantly
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Table 3. Coronary risk factors in 44 dialysis patients who underwent coronary angiography and cardiac atheterizationa
Avg BP
mm Hg Avg
cholesterol
mg/dl
Avg
triglyceride
mg/dl
Smoking
%
LVH
%
Avg
Ca >< P
Avg
Alk Phos
lU/liter
Peak
PTH
pEqimi
Avg
PCV
%Systolic Diastolic
Total 152 86.8 198 224 46.2 56.8 48.8 183 779 26.7
(N = 44)
(37) (32) (39) (43)
1 152 86.8 204 225 56.6 52.9 47.4 173 812 27.6
(N = 34)
(31) (28) (30)
2 153 87 163 219 11.1 70 53.8 220 601 23.7(N = 10)
(6) (4) (8) (4) (9)
Abbreviations: LVH, left ventricular hypertrophy; PCV, packed red cell blood volume.
Values are mean SE except for smoking and LVH which are percentages. The numbers in parentheses represent the sample size when data
were available only for a subset of the whole group.
different. Table 3 shows the distribution of coronary risk factors
in patients in groups 1 and 2. Despite elevated mean serum
cholesterol and triglyceride concentrations, and increased PTH
concentrations in group 1, no significant differences between
the groups could be found using analysis of covariance tech-
niques. Similarly, no significant differences between groups
could be found for serum calcium and serum phosphorus, not
defined in Table 3. Smoking, however, occurred more frequent-
ly in the group catheterized for angina [x2 (1) = 5,78, P =
0.016]. However, when age, race, and sex covariance adjust-
ments were made to the group means, no statistically significant
differences could be found for any of these risk factors. When
the two groups were examined for the presence of angiographic
evidence of 50% or more coronary artery narrowing, we found
that such narrowing was present in only 53% (18 patients) of the
symptomatic group and in 10% (1 patient) of the asymptomatic
group (Table 4) [x2 (1) = 5.81, P = 0.016].
Risk factors associated with significant coronary artery
narrowing
Because only 53% of patients with symptomatic ischemic
heart disease were found to have significant coronary artery
narrowing by angiography, we further analyzed this subgroup
of patients to determine which risk factors were significantly
associated with coronary artery narrowing. Table 5 shows that
those patients with significant coronary artery narrowing (group
1A) were older than those with trivial lesions (group lB) (55
2.7 years vs. 46.0 3.2 years, P = 0.043). The age distribution
for both groups can be seen in Table 6 and revealed that patients
60 years of age and over were found more frequently in group
1A and that patients under 40 years of age were found exclu-
sively in group lB. Moreover, we observed that patients with
involvement of three or more coronary vessels were the oldest
(58.5 6 years). White males far exceeded black patients and
women in the group with angiographic evidence of coronary
artery narrowing [x2 (3) = 10.29, P = 0.016]. No differences
could be found between groups when the etiologies of chronic
renal failure were compared. The interval from the onset of
dialysis to the time of angiography was much shorter in group
1A than in lB (27.3 6.9 months vs. 54.1 8.5 months). This
may have occurred in part because 11 of the 18 patients in group
Table 4. Angiographic documentation of significant occlusion of one
or more coronary vessels in 44 hemodialysis patientsa
Group
50% Coronary artery narrowing
Present Absent
Total 19 (43.2) 25 (56.8)
N=44
Group 1 18 (52.9) 16(47.1)N = 34
Group 2 1 (10) 9 (90)
N = 10
a The numbers in parentheses represent percentages.
1A had symptoms of angina pectoris prior to starting the
hemodialysis program compared to only three in group lB. Of
the potential coronary risk factors denoted in Table 7, mean
systolic BP, mean serum cholesterol, and serum triglyceride
concentrations, peak PTH level, and mean PCV were higher in
group 1A than in group lB. A positive smoking history was
statistically more common in group 1A patients [x2 (1) = 4.69, P
= 0.03]. Abnormal left ventricular wall motion was also found
more commonly in group 1A than in group lB [x2(1) = 5,43, p
= 0.0191. In addition, the cardiac index in 12 patients having
significant coronary artery narrowing was 3.7 0.36 1/min/m2
compared with 5.37 0.56 1/minIm2 for 11 patients with
insignificant disease, (P = 0.011). However, when these factors
were analyzed after age, race, and sex adjustments, none of
these differences, except cardiac index, reached statistical
significance. In addition, mean serum calcium and phosphorus
concentrations, not noted in Table 7, were not different be-
tween groups with and without significant coronary artery
narrowing.
Stepwise discriminant function analysis was used in the
group of patients with anginal chest pain to determine which
risk factors were associated significantly with the presence of
angiographically documented coronary artery narrowing of 50%
or more and which also were found to predict best the subset
patients with significant coronary disease. Six of the 34 patients
were excluded from this analysis because of missing data for
one or more risk factors. The analysis revealed that increased
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Table 5. Demographic characteristics of 34 dialysis patients with angina pectoris with angiographically defined coronary arteriesa
Group
Age
years B
Race
W
Sex
M F
.
Dialysis duration
months
Cause of renal failure
HBP GN CIN UNK Other
IA
Significant coronary 55 0 18 14 4 27.3 6.9 6 2 4 4 2
occlusion (0) (100) (77.8) (22.2) (33.3) (11.1) (22.2) (22.2) (11.1)(N = 18)
lB
Trivial or no coro- 46.0 6 10 6 10 54.1 8.5 6 3 3 1 3
nary occlusion (37.5) (62.5) (37.5) (62.5) (37.5) (18.8) (18.8) (6.3) (18.8)(N = 16)
Abbreviations: B, black; W, white; M, male; F, female; HBP, hypertension; GN, glomerulonephritis; CIN, chronic interstitial nephritis; UNK,
unknown; Other: polycystic disease (2), Fabry disease (1), diabetes mellitus (I), atheroembolic disease (1).
Values represent sample sizes, except for age which is mean sE. Numbers in parentheses represent percentages.
age, increased mean serum cholesterol concentration, the pres-
ence of symptomatic angina prior to the onset of dialysis,
abnormal left ventricular wall motion and, for reasons not well
understood, decreased alkaline phosphatase concentrations
predicted the presence of significant coronary artery disease.
Table 8 shows that 13 patients were predicted to have signifi-
cant lesions but that only 11 of these actually had them, giving
two false positive predictions and a sensitivity of 84.6%. The
model also predicted 15 patients would have no lesions. How-
ever, two of these were observed to have significant lesions.
Thus, there were two false negative predictions for a specificity
of 86.6%.
Five patients underwent two selective coronary angiographic
studies. This group included four white patients and one black,
three of whom were men and two were women. The mean age
of the group was 46.0 4.5 years (range, 32 to 58 years). None
of these patients had 50% or greater narrowing of their coronary
vessels at the time of their initial coronary angiography. When
the second procedure was repeated 22 to 61 months later, no
changes in coronary anatomy were demonstrated.
Cause of death
Twenty-one of the 44 patients in this study died. Table 9
shows the causes of death in this group. Ten of the 21 deaths
could be attributed to heart failure or myocardial infarction. Six
of the ten cardiac deaths, including all the deaths from myocar-
dial infarction, were found in the group with significant coro-
nary artery disease (group 1A).
Seven patients were autopsied at times ranging from 2 weeks
to 5.5 years following coronary angiography. Three patients had
no angiographic evidence of coronary artery disease. At autop-
sy 4 months, 2 years, and 4 years later, the absence of coronary
pathology was confirmed. A fourth patient had 100% occlusion
of the right coronary artery documented angiographically; 5
years later autopsy confirmed this lesion and revealed no new
lesions. The remaining three patients had advanced three-vessel
disease at the time of angiography. This was confirmed at
autopsy in two patients 2 weeks and 5 years following the
procedure. The last patient had angiographic demonstration of
40% narrowing of the left anterior descending artery, but, at
autopsy 1 month later, an additional 70% obstruction of the left
circumflex artery was also discovered.
Table 6. Age distribution of dialysis patients with angina pectoris
angiographically defined coronary artenesa
Group
Age, years
39 40 to 49 50 to 59 60+
IA
Significant coronary
occlusion 0 6 5 7
N = 18 (33.3) (27.8) (38.9)
lB
Trivial or no coro-
nary occlusion 5 4 4 3
N = 16 (31.2) (25) (25) (18.8)
a The numbers in parentheses represent percentages.
Discussion
The present study demonstrates that nearly 50% of 44 hemo-
dialysis patients having angina pectoris had no angiographic
evidence of anatomically significant coronary artery narrowing.
While it is well known that 10 to 30% of nondialysis patients
with angina referred for coronary angiography have normal
coronary arteries or minor atherosclerotic changes [19—21], our
study suggests that this condition is found much more frequent-
ly in the dialysis population. This observation supports the
recent small series of Roig et al [22] which noted normal
coronary arteries in four of nine hemodialysis patients with
angina pectoris. However, our findings differ from those of
Braun et al [23] who found fewer symptomatic patients in the
group with trivial coronary artery disease. We also noted that
only one of the ten asymptomatic patients had angiographic
evidence of significant coronary atherosclerosis which is similar
to the 5 to 10% observed in the general population [24] and
which suggests that there is not an excessive number of dialysis
patients with occult coronary artery disease.
Our observations have important implications for the under-
standing of ischemic heart disease in dialysis patients. First,
since symptoms of ischemic heart disease appear much more
frequently than do the usual determinants of significant coro-
nary artery narrowing by atherosclerosis, our previous assess-
ment of the frequency of atherosclerotic heart disease in
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Table 7. Coronary risk factors in dialysis patients with angina pectoris and angiographically defined coronary arteriesa
Mean BP,
mm Hg Mean
cholesterol
Mean
triglyceride Smoking LVH Mean
Mean
Alk Phos
Peak
PTH
Mean
PCV
Group Systolic Diastolic mg/dl mgldl % % Ca x P lU/liter pEqImI %
IA
Significant coronary 153 86.1 214 238 75 44.4 45.1 122 862 30.5
occlusion ±4.1 ±2.3 ±12.3 ±28.5 ±4.2 ±48 ±294 ±1.5
(18) (16) (15) (17) (10) (17)
lB
Trivial or no coro- 150 87.7 194 208 35.7 67.5 50.1 229 770 24.5
nary occlusion ±4.2 ±2.5 ±11.2 ±34 ±2.5 ±64 ±173 ±1.1
(16) (15) (13) (12)
Abbreviations are the same as those used in Table 3.
a Values are mean ± SE except for smoking and LVH which are percentages. The numbers in parentheses represent sample size when data were
available for only a subset of the whole group.
dialysis populations, [2] which depended on the appearance of
ischemic symptoms, must have overestimated the number of
patients with significant coronary atherosclerosis. Second, our
data suggest that other factors in addition to narrowing of the
coronary arterial caliber must account for this high rate of
angina pectoris seen in dialysis patients.
Myocardial ischemia usually occurs when myocardial oxygen
demand exceeds its oxygen supply. Since, in our study group,
left ventricular hypertrophy was more prevalent in symptomat-
ic patients with trivial coronary artery narrowing, (Table 7), an
excessive myocardial oxygen demand may have existed in
these patients, especially if associated with the common finding
of ECF volume overload. This may have been compounded
further by the finding of a greater degree of anemia in this group
(Table 7), which may have further decreased oxygen delivery to
the myocardial tissue. Given the prevalence of such problems in
dialysis patients, it may be necessary, in this group, to consider
as limiting for myocardial oxygen delivery, a lesser degree of
coronary artery luminal narrowing than the usual 75%. In this
regard, Delano et al [25] have found increased myocardial
lactate production in uremic patients in response to isoprotere-
nol and suggested that in these patients, a normal coronary
artery circulation may have been inadequate to meet the
demands for oxygen. Thus, in the presence of LVH and
anemia, trivial degrees of coronary artery narrowing may have
enormous physiologic importance.
A number of hemodialysis-induced events, when coupled
with anemia and left ventricular hypertrophy, may also precipi-
tate symptoms of ischemic heart disease in patients with or
without significant coronary artery narrowing. For example,
hemodialysis may be associated with reductions in blood P02
[26], alterations in hemogloblin-oxygen affinity [27], reduced
myocardial oxygen balance, and an increased myocardial con-
tractility causing myocardial underoxygenation [28, 29]. Hypo-
tension [30] and increased heart rate [31] are also commonly
seen. Thus, hemodialysis may simultaneously reduce coronary
artery perfusion pressure, coronary artery filling time, and
myocardial oxygen delivery while increasing myocardial oxy-
gen demands. Moreover, coronary artery spasm also may have
accounted for some of our symptomatic patients without coro-
nary artery atherosclerosis, since angina pectoris in two pa-
tients responded to the use of calcium channel blockers.
However, there is no known association between renal failure,
dialysis, and coronary artery spasm. In addition, reduced
coronary artery compliance, perhaps secondary to coronary
artery calcification, has been implicated as a mechanism for
angina pectoris developing in patients with trivial coronary
lesions [15]. Thus, it is possible that coronary artery calcifica-
tion, which occurs with increased frequency in dialysis pa-
tients, may contribute to decreased myocardial oxygen delivery
by restricting coronary vasodilation.
Given the disparity between the appearance of symptomatic
ischemic heart disease and the finding of significant coronary
artery narrowing, it is important to identify those factors which
are highly associated with significant coronary artery narrow-
ing. In a previous study [9], we identified increased age, race,
and increased diastolic BP prior to the onset of dialysis as
important risk factors for the development of symptomatic
IHD. Our current analysis provides a profile of the symptomat-
ic patients most likely to have significant coronary artery
narrowing. We found that increased age, a history of sympto-
matic IHD prior to the onset of dialysis treatment, elevated
mean serum cholesterol concentration, low alkaline phospha-
tase, together with abnormal left ventricular wall motion pre-
dicted the presence of significant narrowing of coronary artery
caliber. Since the majority of the patients having symptomatic
IHD prior to the onset of dialysis were white adult males, we
feel justified in saying that older white males were most likely to
have significant coronary artery lesions. That significant coro-
nary artery disease was found exclusively in white patients was
surprising but agrees with studies demonstrating a greater
prevalence of coronary artery disease in white than in black
patients [32, 33].
Our observations underscore the influence of demographic
factors, in particular age, on coronary risk in dialysis popula-
tions. Since older age is associated with an increasing preva-
lence of coronary artery disease and a higher rate for develop-
ment of endstage renal disease [34], it is important to recognize
that during the past decade the number of dialysis patients over
age 55 has risen from 7 to 46% [35] and that currently 60% of all
hemodialysis patients in our ESRD network (Network 18) are
over age 50 [36]. We have also previously noted and have
confirmed here that older patients had a greater risk for
coronary mortality. Thus, the disproportionate number of older
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Table 8. Prediction of the presence of significant coronary artery
occlusion in hemodialysis patients using discriminant function
analysis'
Observed
50% Corona ry artery narrowing predictedb.
Present Absent Total
Present 11
(84.6)
2
(15.4)
13
(100)
Absent 2
(13.3)
13
(86.6)
15
(100)
Total 13
(46.4)
15
(53.5)
28d
(100)
a The numbers in parentheses are percentages of predictions.
b The model is: Significant disease = 0,1899—0.0147 age—0.0034
serum cholesterol + 0.0007 alkaline phosphatase + 0.2681 prior symp-
toms of IHD + 0.4564 abnormal LV wall motion. Coding used in this
model for prior symptoms of IHD and abnormal LV wall motion are 1 =
present, 2 = absent. A negative predicted value indicates probable
significant disease.
The discriminant function coefficients and their SE are:
Intercept 0.1899 0.5923
Age —0.0147 0.0059
Cholesterol —0.0034 0.0019
Alkaline phosphatase 0.0007 0.0004
Prior ischemic heart disease symptoms 0.2681 0. 1579
Abnormal LV wall motion 0.4564 0.1492
d Six patients did not have one or more risk factors recorded and
were, therefore, excluded from the analysis.
patients in dialysis populations may help explain the continued
high mortality from coronary artery disease.
Unlike our previous study [9], elevated mean total serum
cholesterol concentration was found to be associated with
significant coronary artery narrowing. Elevated serum choles-
terol concentration is an established coronary risk factor in
nondialysis patients. However, serum triglyceride and not
cholesterol is usually elevated in renal failure. Although not all
studies concur, positive associations between coronary artery
disease and serum triglyceride concentrations have been found
in dialysis populations [12—14, 37]. Though not examined, our
finding may reflect an increase in the low density lipoprotein
cholesterol fraction which has been noted to be elevated in
white dialysis patients [38—40]. Thus, our data cannot exclude a
role for abnormal lipids in the atherogenic process primarily
seen in white dialysis patients. Smoking, when examined as a
single variable, was associated strongly with the presence of
coronary artery disease in our dialysis population as has been
suggested by other investigators [12]. However, when analyzed
by discriminant function analysis or when adjustments for age,
race, and sex were made, the association between smoking and
coronary disease was lost as we previously noted [91. Neverthe-
less, despite the absence of statistical importance, we cannot
exclude an effect of smoking on coronary artery disease in our
current population.
The finding of abnormal left ventricular wall motion as an
important predictor of the presence of coronary artery disease,
in conjunction with the above factors, might be helpful to
decide which symptomatic dialysis patients should be studied
by angiography. Although several changes in left ventricular
function have been identified in dialysis populations, none have
been associated with significant coronary artery disease [41]. In
Table 9. Causes of death in dialysis patients with angiographically
defined coronary arteries
Cause of death
Myocardial Heart
Number Unknown infarction failure Otherb
Groupl 14 2 3 3 6
GrouplA 9 2 3 3
GrouplB 5 0 0 0 5
Group2 7 1 0 4a 2
Total deaths 21 3 3 7 8
a The number includes one patient with bacterial endocarditis.
b Other causes of death include infection (3), stroke (I), hypercalce-
mia (1), pancreatitis (1), trauma (1), and uremia (1).
postmortem studies, Hutchins et a! [42] showed abnormal wall
motion in 76 of 77 patients with coronary artery disease, thus
suggesting an association between the two findings. Similarly,
experimental studies show a good correlation between reduc-
tion in myocardial perfusion and the development of segmental
dyskinesis [43].
Five patients underwent selective coronary angiographic
studies 22 to 61 months apart. None of these patients exhibited
evidence of a change in coronary artery caliber or an increase in
the number of atherosclerotic lesions initially seen, The ab-
sence of any reduction in coronary artery caliber over a 2- to 5-
year period and the absence of new lesions seem to suggest that
the atherosclerotic process in these patients was not acceler-
ated. The number of patients studied in this manner was small.
Nevertheless, our present observation supports our earlier
finding in which 33 autopsied patients were examined up to 68
months after the onset of dialysis [21. In this group only seven
(21%) demonstrated significant coronary artery narrowing.
Thus, angiographic and autopsy data do not suggest that
coronary atherosclerosis is unusually prevalent in dialysis pa-
tients nor does it suggest that the rate of its formation is
accelerated.
In summary, the data show that symptoms of IHD far exceed
the presence of significant atherosclerotic coronary artery
narrowing in patients undergoing dialysis, thereby overestimat-
ing the prevalence of significant coronary artery obstruction.
Symptoms of ischemic heart disease occurring in the absence of
significant coronary artery narrowing may result from several
dialysis-associated changes in oxygen delivery and myocardial
oxygen consumption occurring in association with left ventricu-
lar hypertrophy and anemia, Reduced coronary artery compli-
ance and, possibly, coronary artery spasm may also contribute.
From our data, we suggest that demographic variables, particu-
larly age, race, and sex are extremely important in defining
significant coronary artery disease. Together with the presence
of IHD symptoms prior to the onset of dialysis, abnormal left
ventricular wall motion, an increased total serum cholesterol
concentration, and reduced alkaline phosphatase, they were
specific and sensitive predictors of the presence of significant
coronary artery narrowing in dialysis patients.
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